MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • MDS Virtual Congress 2020

    Early cognitive impairment is associated with specific regional cholinergic denervation in Parkinson’s disease

    S. vander Zee, J. Boertien, M. Gerritsen, J. Spikman, T. van Laar (Groningen, Netherlands)

    Objective: To evaluate regional cholinergic correlates of cognitive impairment in newly diagnosed, treatment-naïve Parkinson’s disease (PD) patients. Background: Mild cognitive impairment (PD-MCI) is a common…
  • MDS Virtual Congress 2020

    Hyposmia as a biomarker in patients with Parkinson’s disease and atypical Parkinsonism

    S. Kumaran, A. Ankeeta, S. Chaudhary, P. Bhat, V. Goyal (New Delhi, India)

    Objective: To investigate neural correlates associated with olfactory dysfunction using fMRI and EEG in Parkinsonism. Background: Patients with Parkinsonism experience non-motor symptoms during the onset…
  • MDS Virtual Congress 2020

    Parkinson’s Disease patients with diplopia exhibit visuospatial and visuoperceptive impairment

    W. Naumann, J. Gogarten, S. Schoenfeld, F. Klostermann, F. Marzinzik, K. Schindlbeck (Berlin, Germany)

    Objective: In this study, we investigated Parkinson’s disease (PD) patients with and without diplopia using motor and non-motor assessments, including detailed neuropsychological testing. We hypothesized…
  • MDS Virtual Congress 2020

    SYNGAP1-related intellectual disability with ataxia and late onset of epileptic seizures

    N. Gogatishvili, T. Tkemaladze, V. Skrahina, S. Kasradze, A. Rolfs (Tbilisi, Georgia)

    Objective: To characterize seizures in a patient with SYNGAP1 mutation and the efficacy of antiepileptic drugs (AEDs). Background: SYNGAP1-related intellectual disability is characterized by developmental…
  • MDS Virtual Congress 2020

    Low Educational Level and Wilson’s disease: A direct path to cognitive decline

    J. Lima, F. Rolim, A. Gomes, A. Marinho, V. Mesquita, G. Ferreira, F. Carvalho (Fortaleza, Brazil)

    Objective: To assess cognitive profile of Wilson's Disease (WD) patients in a single tertiary Movement Disorders center in Fortaleza, Ceará, Brazil. Background: WD is an autosomal recessive disorder…
  • MDS Virtual Congress 2020

    Preclinical pharmacology and early clinical development of dopamine D1 positive allosteric modulators (D1PAMs) with therapeutic potential for neuropsychiatric disorders

    K. Svensson, H. Meltzer, K. Biglan (Indianapolis, IN, USA)

    Objective: The objective was to characterize novel dopamine D1PAMs pre-clinically in behavioral and neurochemical models and in phase 1 human studies in healthy volunteers and…
  • MDS Virtual Congress 2020

    The dual cognitive syndrome in Parkinson’s disease: volumetric, morphological and tractometric features

    Q. Devignes, R. Viard, R. Lopes, N. Betrouni, G. Kuchcinski, G. Carey, L. Defebvre, A. Leentjens, K. Dujardin (Lille, France)

    Objective: To assess volumetric, morphological and tractometric features associated with the fronto-striatal and posterior cortical cognitive profiles in Parkinson’s Disease (PD) Background: The dual syndrome…
  • MDS Virtual Congress 2020

    Predicting dementia in the first 6 years of Parkinson’s disease in the ICICLE-PD cohort

    R. Lawson, C. William-Gray, M. Camacho, G. Duncan, T. Khoo, D. Breen, R. Barker, L. Rochester, D. Burn, A. Yarnall (Newcastle upon Tyne, United Kingdom)

    Objective: To determine which baseline cognitive tests in newly diagnosed participants with Parkinson’s disease (PD) predict conversion to dementia (PDD) within six years. Background: Cognitive…
  • MDS Virtual Congress 2020

    Exploring the role of the retrograde procedural memory in PD in the Luxembourg Parkinson’s Disease Study

    L. Pauly, C. Pauly, G. Hipp, M. Hansen, V. Schröder, R. Krüger (Belvaux, Luxembourg)

    Objective: Deepening knowledge of retrograde procedural memory (RPM) in typical Parkinson’s Disease (PD) patients to demonstrate that RPM is impaired in patients with PD. Background:…
  • MDS Virtual Congress 2020

    Candidate plasma miRNAs and EV protein as novel biomarkers in Parkinson’s disease patients with cognitive impairment and dementia

    R.M Wu, Y.Z Tsai, M.C Kuo, Y.u Yoshioka, K.j Ueda, T.k Ochiya, S.P Lin (Taipei, Taiwan)

    Objective: To determine the diagnostic value of circulating miRNAs and the extracellular vesicle proteins for early detection of patients with Parkinson’s disease and mild cognitive…
  • « Previous Page
  • 1
  • …
  • 44
  • 45
  • 46
  • 47
  • 48
  • …
  • 117
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley